Heather Raglin, Editor

Boehringer Ingelheim announced that novel antibody treatment can interfere in the IL-36 signaling pathway, reducing flares.

Examining the genes and signaling pathways of development of atopic dermatitis and tooth agenesis reveals possible link between the two diseases.

In a clinical trial, patients reported improved quality of life after 12 weeks on sonelokimab.

Findings indicate no rebound effect when participants discontinue dupilumab.

Steven Hacker, MD, explains how the electromagnetic resonant scalpel provides a digitized record of the in vivo scalpel path.

The HEROES program wants to make it easier for stylists to recognize scalp conditions and advise their clients to seek medical help.

The study found that using the multi-peptide eye serum twice a day resulted in improved elasticity and firmness.

Aminolevulinic acid 20% topical solution activated by pulsed dye laser and blue light achieves positive results in treating squamous cell carcinoma.

Janssen Pharmaceutical Companies announced its oral treatment for moderate to severe plaque psoriasis will be taken to Phase 3 clinical trials.

The American Acne and Rosacea Society brings attention to the negative emotional effects of acne.

Investigators reported that deucravacitnib improved quality of life and clinical outcomes scores in those with moderate to severe psoriasis.

Studies found that skin treated with vitamin C was smoother and less wrinkled than skin treated with a placebo.

The recent formulation of benzoyl peroxide in a microencapsulated form improves tolerability while reducing lesions in individuals with rosacea.

Safety data is promising, but clinicians are encouraged to utilize proper skin cooling mechanisms.

The ongoing Canadian wildfires are causing poor air quality in the US, which will likely result in more patients seeking help for skin conditions.

The National Rosacea Society has launched a program to identify skin care and cosmetic products that will not irritate sensitive skin.

The OSIRIS open-label study resulted in a reduction of pain and improvement in quality of life for participants.

The American Academy of Dermatology’s new project uses AI to take treatment for individuals with generalized pustular psoriasis to the next level.

Ritlecitinib is the first and only treatment cleared for adolescents with severe alopecia areata.

A new resource to share with patients follows Nina, who shares the mental and emotional toll of psoriasis and how she manages the condition.

The National Psoriasis Foundation found that patients were frustrated by a lack of treatment options.

In a Maui Derm NP+PA Summer poster presentation, investigators revealed that treatment with spesolimab resulted in a reduction of lesions.

Researchers evaluated factors affecting quality of life and what to consider when determining a patient’s psoriasis treatment plan.

A Stanford professor said overcoming toxicity challenges of oral treatment will allow dermatology physicians to provide better care for pediatric patients.

Being armed with the facts about genital warts will make conversations regarding the virus easier on patients and providers.

Physicians talk about the challenges they face with patients as well as available treatment options.

Experts in dermatology discuss non-surgical treatment options for basal cell carcinoma.

In a real-world study, the novel serum REVIVV® showed an increase in hair growth and hair volume.

Women selected will receive mentorship to grow their businesses in a variety of sectors from travel to fashion and everything in between.

Advanced Dermatology and Cosmetic Surgery utilized a streamlining tool to increase their net profit by $9.5 million in 1 year.